课题基金 / 基金详情

Telomerase Transport and Targeting

Telomerase Transport and Targeting
端粒酶运输和靶向
批准号:
6892333
负责人:
MICHAEL P TERNS
金额:
$24.14万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2004
资助国家:
美国
项目状态:
已结题
起止时间:
2004-08-01 至 2008-05-31

项目摘要

项目成果

MICHAEL P TERNS的其他基金

相似基金

相关文献

中文摘要
翻译
描述(申请人提供):人类端粒酶,维持染色体末端端粒的核糖核蛋白酶,在大多数正常体细胞中缺失,在几乎所有癌细胞中都存在。端粒酶的激活诱导细胞永生化,在肿瘤的发生发展中起关键作用。因此,抑制端粒酶活性为治疗几乎所有癌症提供了一种有前途的方法。为了合理设计有效的抑制剂,需要对端粒酶有更好的了解。在人类中,端粒酶包括两个功能必需的亚基:RNA亚基(人端粒酶RNA)和蛋白质亚单位(人端粒酶逆转录酶)。这种酶复合体在癌细胞中组装的位置和机制(可能表明在哪里以及如何靶向端粒酶)尚不清楚。此外,识别端粒酶的其他基本成分将为抑制提供更多的潜在靶点。这一建议的主要目的是详细了解端粒酶在细胞中的运输和组装,并开发一类基于RNA的端粒酶抑制剂,有效地限制或防止癌细胞的生长。体内分析将在非洲爪哇卵母细胞(由于该系统的许多技术优势)和培养的人类细胞(包括原代和癌细胞株)中进行。为了达到我们的目标,我们定义了以下三个特定的目标:目的1:研究功能性端粒酶在体内的生物发生途径;目的2:检测人端粒酶关键成分在正常细胞和癌细胞中的定位和转运;目的3:开发能够阻止癌细胞生长的有效的抗端粒酶核酶。
英文摘要
DESCRIPTION (provided by applicant): Human telomerase, the ribonucleoprotein enzyme that maintains telomeres at chromosome termini, is absent in most normal somatic cells and is present in nearly all cancer cells. Activation of telomerase induces cellular immortalization and is critical for the development and progression of tumors. Thus, inhibition of telomerase activity offers a promising approach for treating nearly all cancers. A better understanding of telomerase is needed to allow rational design of effective inhibitors. In humans, telomerase includes two subunits essential for function: an RNA subunit (human telomerase RNA) and a protein subunit (human telomerase reverse transcriptase). The location and mechanism of assembly of the enzyme complex in cancer cells (which may indicate where and how to target telomerase) is not known. Furthermore, identification of additional essential components of telomerase would provide additional potential targets for inhibition. The major objectives of this proposal are to obtain a detailed understanding of the trafficking and assembly of telomerase in cells, and to develop a class of RNA-based telomerase inhibitors effective at limiting or preventing the growth of cancer cells. In vivo analysis will be performed both in Xenopus oocytes (due to the many technical advantages of the system) and cultured human cells (including primary and cancer cell lines). To address our objectives we have defined the following three specific aims: Aim 1: To investigate the pathway of biogenesis of functional telomerase in vivo Aim 2: To examine the localization and trafficking of key human telomerase components in normal and cancer cells Aim 3: To develop efficacious anti-telomerase ribozymes capable of preventing growth of cancer cells.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CRISPR Capture, Destroy, and Counter-Attack Mechanisms
  • 批准号:
    10165279
  • 项目类别:
  • 资助金额:
    $65.0万
  • 财政年份:
    2016
  • 负责人:
    MICHAEL P TERNS
  • 依托单位:
CRISPR Capture, Destroy, and Counter-Attack Mechanisms
  • 批准号:
    10784187
  • 项目类别:
  • 资助金额:
    $3.91万
  • 财政年份:
    2016
  • 负责人:
    MICHAEL P TERNS
  • 依托单位:
CRISPR Capture and Destroy Mechanisms
  • 批准号:
    9920158
  • 项目类别:
  • 资助金额:
    $54.78万
  • 财政年份:
    2016
  • 负责人:
    MICHAEL P TERNS
  • 依托单位:
CRISPR Capture, Destroy, and Counter-Attack Mechanisms
  • 批准号:
    10398928
  • 项目类别:
  • 资助金额:
    $56.8万
  • 财政年份:
    2016
  • 负责人:
    MICHAEL P TERNS
  • 依托单位:
海外基金